← All Acumen Pharmaceuticals, INC filings

Acumen Pharmaceuticals, INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
ABOS
Acumen Pharmaceuticals, INC
SCHEDULE: Acumen Pharmaceuticals: Murray Jr. Discloses 5% Stake
James B. Murray Jr. has reported beneficial ownership of 5.00% of Acumen Pharmaceuticals' common stock as of April 6, 2026, with a filing delay noted.
NASDAQ
ABOS
Acumen Pharmaceuticals, INC
SCHEDULE: Franklin Resources Reduces Acumen Pharma Stake to 3.8%
Franklin Resources, Inc. reports a reduced beneficial ownership of 3.8% in Acumen Pharmaceuticals, Inc. common stock.
NASDAQ
ABOS
Acumen Pharmaceuticals, INC
SCHEDULE: Sands Capital Discloses 5.6% Stake in Acumen Pharma
Sands Capital Alternatives and affiliated funds reported a 5.6% beneficial ownership stake in Acumen Pharmaceuticals, Inc. as of June 30, 2025.